Lindbrook Capital, LLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$650
-11.2%
29
+61.1%
0.00%
Q2 2023$732
+88.7%
18
+125.0%
0.00%
Q1 2023$388
+153.6%
8
+100.0%
0.00%
Q4 2022$153
-92.4%
4
-90.0%
0.00%
Q3 2022$2,000
+100.0%
40
+110.5%
0.00%
Q2 2022$1,0000.0%19
-17.4%
0.00%
Q1 2022$1,0000.0%23
+43.8%
0.00%
Q1 2021$1,000160.00%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders